ArticleOncogene2025

Increased antiandrogen enzalutamide sensitivity via altering prostate cancer stem cell traits through modulating the androgen receptor-mediated CDR1/circCDR1-AS/miR-1290/BMP4 signaling.

Diwei Huo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.